Harvest One Cannabis Inc

CVE:HVT ISIN:CA41755P1053

Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) (FRA:2CN) is a global cannabis company focused on delivering high quality, innovative cannabis products and technology to regulated markets around the world. Our shareholders have significant exposure to the entire cannabis value chain through three business units, with Harvest One serving as the parent company over horticultural arm United Greeneries and medical arm Satipharm AG. Harvest One's businesses are all strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has a Canadian ACMPR cultivation and sales license, making Harvest One a unique global company with the capacity to commercially cultivate and sell medicinal grade cannabis in a federally regulated environment.

 
 

News

MMJ PhytoTech Ltd (ASX:MMJ) Significantly Expands Duncon Facility Production Capacity with Land Lease Agreement

🕔3/9/2017 9:56:58 AM 7464

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that its wholly-owned subsidiary United Greeneries Holdings Ltd has executed an agreement with Cowichan Tribes in respect to the leasing of a 13-acre land package located adjacent to the Company's existing Duncan Facility.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Half-year Financial Report for Period Ended 31 December 2016

🕔3/1/2017 9:46:57 AM 5523

The directors present their report, together with the financial statements, on the consolidated entity consisting of MMJ PhytoTech Limited (ASX:MMJ) and the entities it controlled at the end of, or during, the half-year ended 31 December 2016.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Announces Harvest One Closes C$25M Placement

🕔2/23/2017 9:28:36 AM 6210

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Canadian-based Harvest One Capital Corp. (CVE:WON.H) has closed the previously reported (January 27, 2017) private placement, raising C$25,000,500 before costs. Pursuant to the Placement, Harvest One issued 33,334,000 Subscription Receipts at a price of C$0.75.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Phase 2 Clinical Trial For Treatment of Epilepsy Underway

🕔2/13/2017 8:23:49 AM 5806

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited ("PTL"), has commenced following Health Authorities' approval, the Phase 2 clinical study into the safety and efficacy of its PTL101 capsules in treating refractory epilepsy in children.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Quarterly Update

🕔2/1/2017 9:31:02 AM 6478

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 31 December 2016.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Announces Harvest One (CVE:WON.H) to Increase Equity Raising to C$25M

🕔1/30/2017 1:07:55 PM 8395

MMJ PhytoTech (ASX:MMJ) is pleased to advise that Canadian-based Harvest One Capital Corp. (CVE:WON.H) has increased its private placement to C$22 million, plus an over-allotment option of up to an additional C$3 million. Under the increased offering, Harvest One may issue up to 33,333,333 subscription receipts at a price of $0.75 per Subscription Receipt.

Read Full Article
###

37,789 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 76) (Last 30 Days: 246) (Since Published: 37789) 

Company Data

    Principal Sector
  • Financial General 
  • Principal Industry
  • Financial Services 
  • Homepage
  • www.harvestone.com